Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Radius Health

9 Disclosed Funding Rounds $687,900,000

0 Participating Investments


Pharmaceutical, Health Care, Biotechnology, Women's, Health Diagnostics

Radius Health develops drug therapies for osteoporosis and women’s health.

Cambridge, Massachusetts, United States, North America (US)

Organizations in Cambridge in Pharmaceutical,
Organizations in Cambridge in Health Care,
Organizations in Cambridge in Biotechnology,
Organizations in Cambridge in Women's,
Organizations in Cambridge in Health Diagnostics,
Organizations in Massachusetts in Pharmaceutical,
Organizations in Massachusetts in Health Care,
Organizations in Massachusetts in Biotechnology,
Organizations in Massachusetts in Women's,
Organizations in Massachusetts in Health Diagnostics,
Organizations in United States in Pharmaceutical,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in United States in Women's,
Organizations in United States in Health Diagnostics,
Organizations in North America in Pharmaceutical,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology,
Organizations in North America in Women's,
Organizations in North America in Health Diagnostics

Investors in Cambridge in Pharmaceutical,
Investors in Cambridge in Health Care,
Investors in Cambridge in Biotechnology,
Investors in Cambridge in Women's,
Investors in Cambridge in Health Diagnostics,
Investors in Massachusetts in Pharmaceutical,
Investors in Massachusetts in Health Care,
Investors in Massachusetts in Biotechnology,
Investors in Massachusetts in Women's,
Investors in Massachusetts in Health Diagnostics,
Investors in United States in Pharmaceutical,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in United States in Women's,
Investors in United States in Health Diagnostics,
Investors in North America in Pharmaceutical,
Investors in North America in Health Care,
Investors in North America in Biotechnology,
Investors in North America in Women's,
Investors in North America in Health Diagnostics

Greater Boston Area (0 Investors) (0 Startups), New England (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 11, 2003

Founders John Potts, John A. Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Debt


Twitter Link

LinkedIN Link

Wikipedia Link

Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. The company's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life. Their long-term focus is on additional areas in women's health that include symptoms of menopause, reproductive disorders, and frailty associated with aging. Radius's scientific leadership includes some of the world's leading researchers in the fields of bone metabolism, endocrinology, and medicinal chemistry, and the company has a broad foundation in nuclear hormone receptors.

Date Round Raised Lead
March, 03, 2021 Debt Financing $175,000,000 -------
August, 08, 2017 Convertible Note $300,000,000 -------
June, 09, 2014 Venture - Series Unknown Undisclosed -------
April, 25, 2013 Private Equity $43,000,000 -------
December, 16, 2011 Private Equity $21,400,000 -------
July, 26, 2011 Series C $66,000,000 MPM Capital, BB Biotech Ventures
November, 20, 2008 Series C $15,000,000 MPM Bio IV NVS Strategic Fund
September, 17, 2007 Series C $10,000,000 MPM Bio IV NVS Strategic Fund
April, 02, 2007 Series B $57,500,000 Wellcome Trust, MPM Capital

Radius Health Investors (34)

Investor Lead? Round Participating Raise Date Partners
Saints Capital No Venture - Series Unknown Undisclosed June, 09, 2014 -------
MPM Capital No Private Equity $43,000,000 April, 25, 2013 -------
BB Biotech Ventures No Private Equity $43,000,000 April, 25, 2013 -------
MPM Bio IV NVS Strategic Fund No Private Equity $43,000,000 April, 25, 2013 -------
Brookside Capital No Private Equity $43,000,000 April, 25, 2013 -------
Biotech Growth No Private Equity $43,000,000 April, 25, 2013 -------
HealthCare Ventures No Private Equity $21,400,000 December, 16, 2011 -------
MPM Capital No Private Equity $21,400,000 December, 16, 2011 -------
Scottish Widows Investment Partnership No Private Equity $21,400,000 December, 16, 2011 -------
BB Biotech Ventures No Private Equity $21,400,000 December, 16, 2011 -------
Saints Capital No Private Equity $21,400,000 December, 16, 2011 -------
Brookside Capital No Private Equity $21,400,000 December, 16, 2011 -------
Wellcome Trust No Private Equity $21,400,000 December, 16, 2011 -------
MPM Capital Yes Series C $66,000,000 July, 26, 2011 -------
Scottish Widows Investment Partnership No Series C $66,000,000 July, 26, 2011 -------
BB Biotech Ventures Yes Series C $66,000,000 July, 26, 2011 -------
Saints Capital No Series C $66,000,000 July, 26, 2011 -------
Brookside Capital No Series C $66,000,000 July, 26, 2011 -------
Wellcome Trust No Series C $66,000,000 July, 26, 2011 -------
HealthCare Ventures No Series C $66,000,000 July, 26, 2011 -------
Scottish Widows Investment Partnership No Series C $15,000,000 November, 20, 2008 -------
BB Biotech Ventures No Series C $15,000,000 November, 20, 2008 -------
MPM Bio IV NVS Strategic Fund Yes Series C $15,000,000 November, 20, 2008 -------
Oxford Bioscience Partners No Series C $15,000,000 November, 20, 2008 -------
MPM Capital No Series C $15,000,000 November, 20, 2008 -------
Wellcome Trust No Series C $15,000,000 November, 20, 2008 -------
HealthCare Ventures No Series C $15,000,000 November, 20, 2008 -------
MPM Bio IV NVS Strategic Fund Yes Series C $10,000,000 September, 17, 2007 -------
Scottish Widows Investment Partnership No Series B $57,500,000 April, 02, 2007 -------
BB Biotech Ventures No Series B $57,500,000 April, 02, 2007 -------
Oxford Bioscience Partners No Series B $57,500,000 April, 02, 2007 -------
Wellcome Trust Yes Series B $57,500,000 April, 02, 2007 -------
MPM Capital Yes Series B $57,500,000 April, 02, 2007 -------
HealthCare Ventures No Series B $57,500,000 April, 02, 2007 -------